Compare AORT & AOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AORT | AOD |
|---|---|---|
| Founded | 1984 | 2006 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 970.0M |
| IPO Year | 1993 | N/A |
| Metric | AORT | AOD |
|---|---|---|
| Price | $44.94 | $9.68 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $49.36 | N/A |
| AVG Volume (30 Days) | 346.5K | ★ 423.5K |
| Earning Date | 11-06-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 12.95% |
| EPS Growth | N/A | ★ 213.63 |
| EPS | N/A | ★ 1.93 |
| Revenue | ★ $422,646,000.00 | $72,962,082.00 |
| Revenue This Year | $15.97 | N/A |
| Revenue Next Year | $10.96 | N/A |
| P/E Ratio | ★ N/A | $4.44 |
| Revenue Growth | ★ 9.81 | N/A |
| 52 Week Low | $21.97 | $6.99 |
| 52 Week High | $48.04 | $9.14 |
| Indicator | AORT | AOD |
|---|---|---|
| Relative Strength Index (RSI) | 51.19 | 57.76 |
| Support Level | $42.68 | $9.63 |
| Resistance Level | $46.02 | $9.74 |
| Average True Range (ATR) | 1.35 | 0.08 |
| MACD | -0.18 | 0.02 |
| Stochastic Oscillator | 53.39 | 80.69 |
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.
Aberdeen Total Dynamic Dividend Fund is a diversified, closed-end management investment company. Its investment objective is to seek high current dividend income. The company also focuses on the long-term growth of capital as a secondary investment objective. The fund invests in foreign securities, including direct investments in securities of foreign issuers and investments in depositary receipts that represent indirect interests in securities of foreign issuers. Its portfolio consists of securities from Information Technology, Financial, Healthcare, and Industrials among other sectors.